The American Society for Pharmacology and Experimental Therapeutics (ASPET) has chosen Kenneth P. Minneman, PhD, Charles Howard Candler Professor of Pharmacology at Emory University School of Medicine, as President Elect, effective July 2006. Dr. Minneman will become President of ASPET in July 2007.
ASPET is one of the oldest and most prestigious societies of pharmacology in the world, and will celebrate its centennial in 2008. It includes ten divisions and four regional chapters, with a national membership of about 4,000, and publishes five journals.
Since he joined the Emory faculty in 1980, Dr. Minneman has been funded for over 25 years by the National Institutes of Health (NIH) for his research in neurochemistry and receptor pharmacology, focusing on adrenergic receptors, which are a key component of signaling mechanisms throughout the body.
Dr. Minneman received his bachelor's degree from the Massachusetts Institute of Technology and his doctorate from the University of Cambridge, England. He has received the ASPET John Jacob Abel Award as the most outstanding young pharmacologist, the PhRMA Foundation Award for Basic Science Career Excellence from the Pharmaceutical Research and Manufacturing Association, and the Dean's Teaching Award from Emory University School of Medicine.
He has served on both the Pharmacology and the Cardiovascular and Renal Study Sections of the NIH, as chair of the Molecular Signaling Study Committee of the American Heart Association, and as a member of the Executive Council of ASPET.
Dr. Minneman is recognized by the Institute for Scientific Information (ISI) as among the world's most highly cited scientific researchers in pharmacology. He has served as associate editor for "Molecular Pharmacology," the "Journal of Pharmacology and Experimental Therapeutics," and "Pharmacological Reviews and Communications."